Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kymera Therapeutics, Inc. (KYMR)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 84,917,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Kymera Therapeutics is a biopharmaceutical company focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Co.'s proprietary targeted protein degradation platform, which Co. refers to as Pegasus™, allows Co. to discover selective small molecule protein degraders with activity against disease-causing proteins throughout the body. Co. has utilized its Pegasus™ platform to design protein degraders focused in the areas of immunology-inflammation and oncology, and Co. continues to apply its platform's capabilities to additional therapeutic areas.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 2,005,813 2,005,813 2,978,480 2,978,481
Total Buy Value $172,499,918 $172,499,918 $215,297,266 $215,297,312
Total People Bought 1 1 2 2
Total Buy Transactions 1 1 3 4
Total Shares Sold 478,458 655,368 732,191 2,190,967
Total Sell Value $41,872,855 $51,446,278 $54,825,558 $113,861,164
Total People Sold 5 6 9 11
Total Sell Transactions 9 14 24 53
End Date 2025-10-19 2025-07-18 2025-01-17 2024-01-18

   
Records found: 280
  Page 1 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mainolfi Nello Chief Executive Officer   •       •      –    2026-01-05 4 OE $32.07 $99,994 D/D 3,118 666,195     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2025-12-31 4 AS $77.95 $2,341,939 D/D (30,000) 663,077     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2025-12-31 4 OE $2.08 $62,400 D/D 30,000 693,077     -
   Esposito Pamela   –       •      –    2025-12-17 4 AS $81.56 $2,264,480 D/D (27,563) 0     -
   Esposito Pamela   –       •      –    2025-12-17 4 OE $27.67 $1,042,483 D/D 27,563 27,563     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2025-12-17 4 OE $38.53 $99,985 D/D 2,595 663,077     -
   Booth Bruce   –       •      –    2025-12-12 4 S $91.04 $61,725 I/I (678) 685,393     -
   Booth Bruce   –       •      –    2025-12-11 4 S $91.23 $556,594 I/I (6,101) 685,501     -
   Baker Julian   –       •       •   2025-12-11 4 B $86.00 $172,499,918 I/I 2,005,813 7,955,916 0.01     -
   Booth Bruce   –       •      –    2025-12-10 4 S $88.64 $21,080,724 I/I (229,809) 686,477     -
   Gollob Jared Chief Medical Officer   •       –      –    2025-12-08 4 AS $87.37 $4,371,833 D/D (49,307) 109,992     -
   Gollob Jared Chief Medical Officer   •       –      –    2025-12-08 4 OE $5.33 $262,806 D/D 49,307 159,299     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2025-12-08 4 AS $89.17 $8,917,000 D/D (100,000) 660,482     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2025-12-08 4 OE $2.08 $208,000 D/D 100,000 760,482     -
   Albers Jeffrey W.   –       •      –    2025-12-08 4 AS $89.32 $448,823 D/D (5,000) 0     -
   Albers Jeffrey W.   –       •      –    2025-12-08 4 OE $14.18 $70,900 D/D 5,000 5,000     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2025-10-29 4 AS $59.72 $1,829,737 D/D (30,000) 660,482     -
   Mainolfi Nello Chief Executive Officer   •       •      –    2025-10-29 4 OE $2.08 $62,400 D/D 30,000 690,482     -
   Gollob Jared Chief Medical Officer   •       –      –    2025-10-15 4 AS $60.37 $3,659,254 D/D (59,576) 109,992     -
   Gollob Jared Chief Medical Officer   •       –      –    2025-10-15 4 OE $1.31 $84,185 D/D 51,209 169,568     -
   Albers Jeffrey W.   –       •      –    2025-10-13 4 AS $59.19 $295,949 D/D (5,000) 0     -
   Albers Jeffrey W.   –       •      –    2025-10-13 4 OE $10.34 $51,700 D/D 5,000 5,000     -
   Gollob Jared Chief Medical Officer   •       –      –    2025-10-13 4 AS $60.00 $186,840 D/D (3,114) 118,359     -
   Gollob Jared Chief Medical Officer   •       –      –    2025-10-13 4 OE $1.31 $2,448 D/D 1,473 121,473     -
   Jacobs Bruce N. Chief Financial Officer   •       –      –    2025-09-17 4 AS $50.00 $3,961,380 D/D (79,220) 227,409     -
  280 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2026 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us